Beta-BioLED will be the first medical device targeted to mass-market that performs a complete blood analysis. It keeps the core technique of current hospitals’ analyzers and integrates it in a small and affordable device. Beta-BioLED will make a significant difference in peoples’ lives allowing everyone to know their health status anywhere at anytime.
Co-founded and organized with Xavier Duportet (MIT – INRIA Constraint Groups), Hello Tomorrow Challenge is a unique event to empower young european innovators (more than 1200 startups selected).
Executive Business Accelerator – Jury of the Hello Tomorrow Challenge, 17 – 18 April 2014.